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Abstract
Developing a knowledge-driven contemporaneous health index (CHI) that can precisely reflect the underlying patient condition
across the course of the condition’s progression holds a unique value, like facilitating a range of clinical decision-making opportu-
nities. This is particularly important for monitoring degenerative conditions such as Alzheimer’s disease (AD), where the condition
of the patient will decay over time. Detecting early symptoms and progression signs, and continuous severity evaluation, are all
essential for disease management. While a few methods have been developed in the literature, uncertainty quantification of those
health index models has been largely neglected. To ensure the continuity of the care, we should be more explicit about the level
of confidence in model outputs. Ideally, decision-makers should be provided with recommendations that are robust in the face of
substantial uncertainty about future outcomes. In this paper, we aim at filling this gap by developing an uncertainty quantification
based contemporaneous longitudinal index, named UQ-CHI, with a particular focus on continuous patient monitoring of degen-
erative conditions. Our method is to combine convex optimization and Bayesian learning using the maximum entropy learning
(MEL) framework, integrating uncertainty on labels as well. Our methodology also provides closed-form solutions in some impor-
tant decision making tasks, e.g., such as predicting the label of a new sample. Numerical studies demonstrate the effectiveness of
the proposed UQ-CHI method in prediction accuracy, monitoring efficacy, and unique advantages if uncertainty quantification is
enabled in practice.
Keywords: Uncertainty quantification, Patient monitoring, Convex optimization, Bayesian learning
1. Introduction
The effective monitoring of degenerative patient conditions
represents a significant challenge in many clinical decision-
making problems and has given rise to the development of nu-
merous mathematical and computational models [1–4]. Devel-
oping a knowledge-driven contemporaneous health index (CHI)
that can precisely reflect the underlying patient condition across
the course of the condition’s progression holds a unique value,
like facilitating a range of clinical decision-making opportu-
nities [5–7], enhancing the continuity of care, and facilitating
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communications between clinicians, healthcare providers, and
patients. It will also be a crucial enabling factor for the devel-
opment of many envisioned AI systems to implement adaptive
interventions for better healthcare management, given a repre-
sentation of the dynamic evolution of the patient’s condition.
Thus, to ensure continuity of care, we should be more ex-
plicit about our level of confidence in model outputs. Ide-
ally, decision-makers should be provided with recommenda-
tions that are robust in the face of substantial uncertainty about
future outcomes. However, computational models are an ab-
straction of clinical observations, as such, they are usually built
on analytically tractable assumptions that may simplify the real-
world problem. Also, most of these models are estimated from
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imperfect data, subjecting them to all kinds of statistical errors.
An approach that yields only a single prediction doesn’t ade-
quately reflect any uncertainty, neither in the empirical data nor
the estimated parameters [8]. As a result, the outcomes from
such mathematical models may not be consistent with the clin-
ical observations. Uncertainty is an unavoidable feature that
affects prediction capabilities in real-world domains such as
healthcare [9, 10], manufacturing [11, 12], signal processing
[13, 14], and etc. A certain amount of uncertainty is always in-
volved in decision-making systems that do not encounter sam-
ples when the experimental data are insufficient to calibrate. In
such cases, there is always a chance that the model parameters
be determined unambiguously even in the existence of complex
mathematical models. In clinical predictions, it is necessary to
deal with such uncertainty in an effective manner, because if the
model parameters are not well constrained, the resulting predic-
tions may represent an unacceptable degree of posterior uncer-
tainty. What is more, while most existing models in patient
monitoring generate one single prediction without telling con-
fidence level, uncertainty quantification could tell us on which
samples we may not be ready to act based on the model. There-
fore, to develop a reliable model for a clinically relevant pre-
diction, uncertainty quantification is a much-needed capacity
[15–17].
A number of patient monitoring index approaches have been
developed in the literature. A standard formulation of these
health indices is to use weighted sum models (e.g., regression
models), and combine multiple static clinical measurements to
predict the disease condition. For example, there exist many
risk score models to predict AD by using multi-modality data
integration methods [18–20] to combine neuroimaging data
[21, 22], genomics data [23], clinical data [24], etc. There are a
few approaches that have formulated the decline of AD-related
score over time as a multi-task learning model [25, 26]. These
existing efforts have been limited to combining static data rather
than longitudinal data. Besides, these data are usually sam-
pled at irregular time points, which adds in another layer of
complexity to the modeling efforts. Our problem’s objective
is fundamentally different from the existing risk score mod-
els; we focus on developing the contemporaneous health in-
dex (CHI) that can fuse irregular multivariate longitudinal time
series dataset to quantify the severity of degenerative disease
conditions that are required to fit the monotonic degradation
process of the disease condition. For example, in our previous
work [27] to address the patient heterogeneity, we developed
a dictionary learning-based contemporaneous health index for
degenerative disease monitoring, called DL-CHI, that leveraged
the knowledge of the monotonic disease progression process to
fuse the data by integrating CHI with dictionary learning. The
basic idea of DL-CHI was learning individual models via the
CHI formulation, and then rebuilding the model parameters of
each patient’s models through a supervised dictionary learning.
However, both CHI and DL-CHI frameworks only generate one
single prediction value for a sample and ignore the sampling
uncertainty (i.e., it is common in healthcare that the label in-
formation is usually obtained by subjective methods which are
subject to uncertainty). Therefore, if we could enable CHI to
conduct uncertainty quantification and incorporate the uncer-
tainty in labels in its modeling, we can widen its applicability
in real-world contexts. The main objective of this paper is to
develop a framework that can focus on the contemporaneous
health index (CHI) developed in [28], and can further equip
CHI with uncertainty quantification capacity.
In this paper, we develop the uncertainty quantification based
contemporaneous longitudinal index, named UQ-CHI, with a
particular focus on continuous patient monitoring of degener-
ative conditions. Our method is to combine convex optimiza-
tion and Bayesian learning using the maximum entropy learn-
ing (MEL) framework, integrating uncertainty on labels as well.
The basic idea of MEL is to identify the distribution of the pa-
rameters of a statistical model that bears the maximum uncer-
tainty, a principle that is conservative and robust [29–31]. It has
been investigated in a few machine learning models [32–35] as
well. For example, in [32], MEL was used to learn a distri-
bution of the parameters in the support vector machine model
rather than a single vector of the parameters. This distribution
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of the parameters could help us evaluate the uncertainty of the
learned support vector machine model and translate into the un-
certainty of predictions.
To adapt the MEL formulation and to develop UQ-CHI, few
challenges should be addressed. The objective function of
MEL, as its distinct feature, bears the full spirit of maximum en-
tropy: no matter what is the model, we are studying, the learn-
ing objective of MEL is to learn the distribution model of the
parameters of the model that has the maximum entropy. If there
is a prior distribution of the parameters, the Kullback–Leibler
divergence could be used to extend this idea. In our case, the
design of the prior distribution should be studied to account for
label uncertainties. Besides the objective function, the MEL
encodes information from the data into constraints, e.g., if the
model is for classification, for each sample, there would be a
constraint that the expectation of the prediction over the distri-
bution of the parameters should match the observed outcome on
this sample. In our case, we will derive the constraints from the
CHI model and integrate with the MEL framework. In detail,
we consider two steps in our method, i.e., training and predic-
tion. In the training step, we consider a prior uncertainty over
the labels to handle uncertain or incomplete labels. Then we de-
rive a solution to the optimization problem by using a specific
prior formulation. In the second step, we develop a prediction
method, with a rejection option method, for new samples with
the obtained uncertainty quantification capacity. A distinct fea-
ture of our model is that it provides a closed-form solution for
predicting the label of a new example. The whole pipeline of
this UQ-CHI model is shown in Figure 1.
The remainder of this paper is organized as follows: in Section
2, we will review related literature in modeling the contempo-
raneous health index for degenerative conditions and the MEL
framework. In Section 3, the UQ-CHI framework will be pre-
sented. In Section 4, we will implement and evaluate the UQ-
CHI using a simulated dataset. We then continue the numerical
analysis with a real-world application on Alzheimer’s disease
dataset in Section 5. We will conclude the study in Section 6.
Note that, in this paper, we use lowercase letters, e.g., x, to rep-
resent scalars, boldface lowercase letters, e.g., v, to represent
vectors, and boldface uppercase letters, e.g., W, to represent
matrices.
2. Related works
In this section, we will first briefly present the basic formu-
lation of the contemporaneous health index (CHI) model, and
its extension, the dictionary learning based contemporaneous
health index (DL-CHI), then we will present the proposed
model: the UQ-CHI.
2.1. The CHI model
The CHI model is developed in [28] which exploits the mono-
tonic pattern of disease over the course of progression to im-
prove further the data fusion of multivariate clinical measure-
ments taken at irregular time points. The CHI framework was
inspired by the common characteristics of degenerative condi-
tions (e.g., AD) that often cause irreversible degradation. For
example, in AD, to measure the degradation of the neural sys-
tems a number of biomarkers were developed, including neu-
roimaging modalities such as PET and MRI scans [36, 37].
For example, MRI scans show a decline in the brain volume
over time along with the disease progression. The same phe-
nomenon could be observed on the PET scans when there is
a persistent shrinkage of metabolic activities. Such monotonic
patterns indicate that once the disease progression started, it
tends to deteriorate over time increasingly. The task of CHI is
to translate multivariate longitudinal and irregular clinical mea-
surements into a contemporaneous health index hn,t to capture
the patient’s condition changing over the course of progres-
sion. Note, clinical measurements for each patient could be
taken with different length of time and at different time loca-
tions. Targeting degenerative conditions, CHI is designed to
be monotonic, i.e., hn,t1 ≥ hn,t2 if t1 ≥ t2, while higher index
represents a more severe condition. CHI is a latent structure;
hence, clinical variables associated with it should be measured
over time to facilitate data for learning the index.
3
Figure 1: A conceptual overview of the UQ-CHI method
Let, xn,t =
[
xn,1,t, . . . , xn,d,t
]T ∈ Rd, denote a training set of N
patients. Each measurement xn,i,t, is the value of the ith variable
for the nth subject in a given time t, where t ∈ {1, . . . ,Tn} is the
time index. our goal is, given a training set, convert each mea-
surement xn,t into an health index hn,t, which requires a math-
ematical model of hn,t = f (xn,t). For simplicity, multivariable
form of the hypothesis function hn,t was studies in [28], i.e.,
hn,t = xn,t.w, where w ∈ Rd is a vector of weight coefficients
that combines the d variables. The total number of positive
and negative samples is shown by N+ and N− respectively, i.e.,
N+ := |{n|yn = 1}| and N− := |{n|yn = −1}|. The formulation of
the CHI learning framework is shown in below:
min
w,b
1
2
‖w‖2+ (1a)
β
∑
n∈{1,...,N}
max
(
0, 1 − yn(x>n,Tn w + b)
)
+ (1b)
α
∑
n∈{1,,...,,N}
t∈{1,...,Tn−1}
max
(
0, 1 − z>n,tw
)
+ (1c)
λ
2
(
1
N+
∑
n∈{N+ |yn=1}
(
(xn,Tn − x¯+Tn )T w
)2)
+ (1d)
λ
2
(
1
N−
∑
n∈{N− |yn=−1}
(
(xn,Tn − x¯−Tn )T w
)2)
+ (1e)
γ‖w‖1. (1f)
Items in (1) can be explained as follows:
• The first term (1a) and the second term (1b) are derived
from a general formulation of support vector machine
(SVM). These two terms are used to enhance the discrim-
inatory power of CHI by utilizing the label information.
Here, yn ∈ {1,−1} is the label of the nth sample that indi-
cates if the nth subject has the disease or not.
• To accommodate the monotonic pattern of disease pro-
gression, and to enforce the monotonicity of the learned
health index, the term (1c) is invented, i.e., hn,t1 ≥ hn,t2 if
t1 ≥ t2. Here, zn,t is the difference of two successive data
vectors zn,t := xn,t+1 − xn,t.
• To encourage the homogeneity of CHI within the group
that has the same health status terms (1d) and (1e) are
invented. Here, x¯+Tn and x¯
−
Tn
represent the center of data
vectors at time Tn for all positive and negative samples,
respectively, that are,
x¯+Tn :=
1
N+
∑
n∈{n|yn=1}
xn,Tn
x¯−Tn :=
1
N−
∑
n∈{n|yn=−1}
xn,Tn .
• To encourage sparsity of the features, L1-norm penalty is
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used as shown in the last term (1f).
The CHI formulation can be solved by using the block coordi-
nate descent algorithm that is illustrated in [28]. Note, the CHI
formulation generalizes many existing models, such as SVM,
sparse SVM, LASSO, etc.
2.2. The DL-CHI model
CHI formulation is designed for learning a model for the aver-
age of a population, and thus, ignores the patient heterogeneity.
Patients who suffer from AD have very heterogeneous progres-
sion patterns [38–40]. Building a personalized model on an
individual basis could be used to consider the heterogeneity.
However, such models require a significant amount of labeled
training samples, which is not feasible in such clinical settings.
Towards this goal, the DL-CHI approach was further developed
in [27] by integrating CHI with dictionary learning [38, 41].
Dictionary learning algorithms reconstruct the input signals as
an approximated signal via a sparse linear combination of a few
dictionary elements or basis [42] (each column of the dictionary
represents a basis vector). Dictionary learning algorithms can
reveal the hidden structures in the data (in a similar spirit as
principal component analysis) by spanning the space of a per-
sonalized model and capturing patient heterogeneity. They play
a role in the regularization of the model learning, in a way that
each dictionary basis vector can be viewed as the numerical
representations of patient heterogeneity. Thus, DL algorithms
can improve the classification performance. Translating this
wisdom into DL-CHI, the basic idea is first to learn individual
models through the CHI formulation, and then, reconstruct the
model parameters of the individual learned models via super-
vised dictionary learning. As such, each model is represented
as a sparse linear combination of the basis vectors. Numerous
experiments in both simulated and real-world data have shown
the effectiveness of DL-CHI in creating personalized CHI mod-
els.
Despite accounting the patient heterogeneity, DL-CHI ignores
the sampling uncertainty, therefore limits its applicability in
real-world applications. Thus, this motivates us to enable CHI
to conduct uncertainty quantification.
2.3. The MEL formulation
As mentioned in Section 1, MEL formulation has a distinct ob-
jective function that aims to learn the distribution of the param-
eters of a model that encodes maximum uncertainty (i.e., evalu-
ated by the entropy concept). It also has constraints that encode
information from the data, e.g., if the model is for classification,
for each sample, there would be a constraint that the expectation
of the prediction over the distribution of the parameters should
match the observed outcome on this sample. To further illus-
trate some details, one typical application of the MEL is the
maximum entropy discrimination (MED) method that focuses
on the application of MEL on classification models.
Let’s consider a binary classification problem, where the re-
sponse variable y takes values from {+1,−1}. Let xn =
[x1, . . . , xn] be an input feature vector andD(xn|w) be a discrim-
inant function parameterized by w, and γ e.g.,D(xn|w) = wT xn.
The training set is defined by D = {xn, yn}Nn=1 and the hinge loss
is defined as h(x) = max(0, yiD(xn|w)). The classification mar-
gin is defined as ynD(xn,w), and it is large and positive when
the label yn agrees with the prediction. Traditional learning ma-
chines such as the max-margin methods learn the optimal pa-
rameter setting w, γ by the empirical loss and the regularization
penalty as shown below:
min
(w,γn)
R(w) +
∑
n
L(γn)
s.t. ynD(xn | w) − γn ≥ 0, ∀n
(2)
Where L() is the loss function which is a non-increasing and
convex function of the margin, and R(w) is the regularization
penalty. However, MED considers a more general problem of
finding a distribution p(w, γ) over w and classification margin
parameters γ. This could be done by minimizing its relative
entropy with respect to some prior target distribution p0(w, γ)
under certain margin constraints. Specifically, suppose that a
prior distribution, denoted as p0(w, γ), is available, then MED
learns a distribution p(w, γ) by solving a regularized risk mini-
mization problem. When the prior distribution is not a uniform
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distribution, this can be generalized as minimizing the relative
entropy (or Kullback-Leibler divergence) and the regularization
penalty as follows (penalizing larger distances from priors):
min
p(w,γ)
KL
(
p(w, γ)||p0(w, γ)) + CR(p(w, γ)). (3)
Here, C is a constant and R(p
(
w, γ)
)
=∑
n h
(
ynEp(w,γ)[D(xn|w) − γn]) is the hinge-loss that captures
the large-margin principle underlying the MED prediction rule:
yˆ = sign
(
Ep(w,γ)[D(xn|w) − γn])). (4)
And the KL divergence is defined as follows:
KL
(
p(w, γ)||p0(w, γ)) = ∫ p(w, γ) log p(w, γ)p0(w, γ) . (5)
Here in (3), the classification margin quantities are included;
γn as slack variables in the optimization, which represents the
minimum margin that ynD(xn|w) must satisfy. MED considers
an expectation form of the traditional approaches and casts Eq.
(2) as an integration. The classification constraints will also be
applied in an expected form. As a result, MED no longer finds
a fixed set of the parameters, but a distribution over them, and it
uses a convex combination of discriminant functions rather than
one single discriminant function to make model averaging for
decisions. In particular, MED formulation finds distributions
that are as close as possible with the prior distribution over all
parameters regarding KL-divergence subject to various moment
constraints. This analogy extends to cases where the distribu-
tions are also over unlabeled samples, missing values, or other
probabilistic entities that are introduced when designing the dis-
criminant function. Correspondingly, MED is an effective ap-
proach to learn a discriminative classifier as well as consider
uncertainties over model parameters, which combines genera-
tive and discriminative learning [35, 43]. This generalization
facilitates a number of extensions of the basic approach, in-
cluding uncertainty quantification described in this paper. The
present work contributes by introducing a novel generalization
of CHI formulation by integrating the MED to perform the task
of uncertainty quantification.
3. The proposed work: the UQ-CHI model
The overall goal of UQ-CHI is to learn a distribution p(w) over
the parameters of CHI model w. An additional goal is that this
could be done even if only partial labels are given, and the la-
bels might also be with uncertainty. Therefore, the first step in
constructing the UQ-CHI is to create the constraint structure.
To design the UQ-CHI, we incorporate some features from the
original formulation of the CHI via Eq. (1) as follows: First,
we utilize the label information by defining the discriminant
functionD(xn,Tn|w) = wT xn,Tn which corresponds to (1b). We,
then incorporate the distinct feature of the CHI formulation, the
monotonicity regularization function M(zn,t |w) = wT zn,t that
corresponds to Eq. (1c). Note that, here, we will not incorporate
the additional terms in Eq. (1d) and Eq. (1e) as they demand
full knowledge of labels of the samples. In addition, we don’t
include the sparsity regularization term (1f), since our focus is
to learn p(w) rather than the parameter vector w. Also, our
model can induce sparsity, e.g., if we impose a Laplace prior
distribution for the parameters as to what is done in Bayesian
Lasso model [44].
In the following subsections, we will introduce how we de-
sign the prior distributions, the constraints, and how to derive
computational algorithms and closed-form solutions for train-
ing and prediction.
3.1. Design of constraints and prior distributions
As aforementioned, there are two types of constraints that
we can extract from the CHI formulation into the develop-
ment of UQ-CHI. One corresponds to the discriminant func-
tion D(xn,Tn|w) = wT xn,Tn used in CHI, to generate prediction
on samples, while the other one corresponds to the monotonic-
ity regularization function M(zn,t |w) = wT zn,t. Based on the
CHI formulation, it is supposed that the model should lead to
ynD(xn,Tn|w) = 1 and M(zn,t |w) ≥ 0. As this perfect model
may not exist, a set of margin variables γ = [γ1, . . . , γn] are
introduced. We consider an expectation form of the previous
approach and cast Eq. (1) as an integration. Hence, the classi-
fication constraints are applied in an expected sense. This will
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lead to the following formulation for the constraints:∫
p(w, γ)[p(yn)D(xn,Tn | w) − γn]dwdγ+ (6a)∫
p(w, γ)
[M(zn,t |w) − γn]dwdγ ≥ 0. (6b)
Here, the term (6a) is the discriminant function and the term
(6b) is the monotonicity regularization function. And, p(yn) is
the distribution of yn, and p(w, γ) is the distribution of w, γ.
With the prior distribution, we can derive the prediction rule:
yˆ = sign(Ep(w)[D(xn|w])).
Now we move on to the design of the prior distribution
p0(w, γ, y). It is natural to decompose the joint prior distribution
as a product of three distributions:
p0(w, γ, y) = p0(w)
N∏
1
p0(γn)
N∏
1
p0(yn). (7)
In what follows we discuss each of the three prior distribu-
tions. Specifically, it is reasonable to assume that a level of
uncertainty can be designed to each example in defining p0(yn).
A simple solution is to set p0(yn) = 1 whenever yn is observed
and p0(yn) = 0.5 otherwise. To define p0(w), we choose p0(w)
to be a Gaussian distribution with mean vector as 0 and co-
variance matrix as an identity matrix I. To define the prior
over the margin variables, we assume that it could be factor-
ized p(γ) =
∏
n p0(γn). Further, following the idea proposed in
[32], we can set p0(γn) = ce−c(1−γn) and γn ≤ 1. Here, 1 − 1c is
actually the mean of the prior distribution of γn, so the idea of
this distribution is to incur a penalty only for margins smaller
than 1 − 1c , while for margins larger than this quantity are not
penalized. More details about the design of prior distributions
will be given in Section 3.4.
3.2. The computational algorithm for UQ-CHI
The full formulation of the proposed UQ-CHI model is shown
below:
min
p(w,γ)
KL
(
p(w, γ)||p0(w, γ)) (8a)
s.t.
∫
p(w, γ)[p(yn)D(xn,Tn | w) − γn]dwdγ+ (8b)∫
p(w, γ)
[M(zn,t |w) − γn]dwdγ ≥ 0. (8c)
Essentially, solving optimization formulation Eq. (8) is to find
a solution by calculating the relative entropy projection from
the overall prior distribution p0(w, γ, y) to the admissible set
of distributions p that are consistent with the constraints. In
what follows, we develop the computational algorithm to solve
this formulation Eq. (8) and further derive the method for the
prediction on samples.
3.2.1. Step 1: Training the model
In the training step, we consider a joint distribution of w, and
the margin vector of γ = [γ1, . . . , γn] while fixing p(yn). In
this step, we first explain the solution to the MED optimization
problem subject to the terms in (3).
Lemma 3.1. Let the loss function be a non-increasing and con-
vex function of the margin, and let the Lagrangian of the opti-
mization problem defined as L and λ = [λ1, . . . , λn] be a set
of non-negative Lagrange multipliers. Given the prior distribu-
tion p0(w) and the model distribution p(w), and the discrimi-
nant functionD(xn|w) in order to minimize the relative entropy
in terms of the KL-divergence (KL(p(w||p0(w)) subjected to set
of defined constraints, the MED optimization problem (3) can
be written as:
max
λ
J(λ) = −logZ(λ)
s.t. λi ≥ 0 for i = 1, . . . ,N
(9)
Here, Z(λ) is the normalization constant defined as:
Z(λ) =
∫
p0(w) exp
(∑
n
λnynD(xn|w)
)
dw, (10)
The proof of Lemma 3.1 can be found in Appendix A. Now,
the model training problem is revealed to be another optimiza-
tion problem, that is learning optimal λ∗ by solving the dual
objective function J under positivity constraint. Based on the
results from Lemma 3.1, after adding dual variables for the con-
straint in Eq. (8), the Lagrangian of the optimization problem
can be written as:
L =
∫
p(w, γ) log
p(w, γ)
p0(w, γ)
dwdγ−( ∑
n∈{1,...,N}
∫
p(w, γ)λn[p(yn)D(xn,Tn | w) − γn]dwdγ+
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
∫
p(w, γ)λn
[M(zn,t |w) − γn]dwdγ).
(11)
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In order to find a solution, we require:
∂L
∂p(w, γ)
= log
p(w, γ)
p0(w, γ)
+ 1−( ∑
n∈{1,...,N}
λn[p(yn)D(xn,Tn | w) − γn]+
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λn
[M(zn,t |w) − γn])
= 0,
(12)
Which results in the following theorem.
Theorem 3.2. The solution to the UQ-CHI problem has the
following general form:
p(w, γ)∗ =
1
Z(λ)
p0(w, γ)
exp
( ∑
n∈{1,...,N}
λn[p(yn)D(xn,Tn | w) − γn]+
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λn
[M(zn,t |w) − γn]).
(13)
Thus, finding the solution to (8) depends on being able to eval-
uate the normalization constant Z(λ).
Lemma 3.3. Let Z(λ) be the normalization constant defined in
Eq. (10). Based on the finding in (13), Z(λ) can be reformulated
as follows:
Z(λ) = Zw(λ) + Zγ(λ) (14a)
= exp
(
1
2
( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
)T
(14b)
( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
))
+ (14c)
∏
n∈{1,...,N}
1
1 − λn/c exp(−λn). (14d)
Where, Zw(λ) is defined in (14b) and (14c) Zγ(λ) is defined in
(14d).
The proof of Lemma 3.3 can be found in the Appendix B.
Given the reformulated normalization constant Z(λ) in (14), the
maximum of the jointly concave function objective function
J(λ) showing in Eq. (9) can be found through a constrained
non-linear optimization. As a result, by substituting Eq. (14) in
Eq. (9) we get:
J(λ) =
∑
n∈{1,...,N}
(
λn + log(1 − λn/c)
)
−
1
2
( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
)T
( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
)
.
(15)
Here, λ ≥ 0. Thus, we have the following dual optimization
problem:
max
λ
∑
n∈{1,...,N}
(
λn + log(1 − λn/c)
)
−
1
2
( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
)T
( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
)
s.t. λ ≥ 0
(16)
The Lagrange multiplier λ, is recovered by solving the convex
optimization problem Eq. (16). Note that since the prior factor-
izes across w, γ, UQ-CHI solution also factorized as well, i.e.,
p(w, γ) = p(w)p(γ).
Corollary 3.4. From results in Theorem 3.2 the marginal dis-
tribution p(w) can be found as follows:
p(w) =
1
Zw(λ)
p0(w) exp
( ∑
n∈{1,...,N}
λn pn(yn)wT xn,Tn+
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnwT zn,t
)
.
(17)
Where, Zw(λ) can be obtained from Eq. (14b) and (14c).
3.2.2. Step 2: Prediction
After obtaining the marginal distribution p(w) in (17), the fol-
lowing lemma is used to predict the label of a new example
xnew. Referring to the solution of the UQ-CHI problem in (13),
we can easily modify the regularization approach for predict-
ing a new label from a new input sample xnew that is shown by
yˆ = signD(x|wˆ). In what follows, we generate the predictive
label for the upcoming new labels.
Lemma 3.5. Given the marginal distribution p(w) in
(17) and the convex combination of discriminant functions
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∫
p(w)D(x|w)dw, and let λ∗ be the optimal Lagrangian mul-
tiplier obtained from the optimization problem (16), and given
Zw(λ) obtained from (14d), then the predictive label for the new
(xnew) can be generated as:
yˆ = sign
(( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn +
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
)T
xnew
)
.
(18)
The proof of Lemma 3.5 is shown in Appendix C.
3.2.3. Summary of the algorithms
A full description of the training and prediction of UQ-CHI
model is given in Algorithm 1.
Algorithm 1 The UQ-CHI algorithm
Require: xn,t ∈ Rd, p0(yn), p0(w), and p0(γ)
Ensure: Generate predictive labels for the upcoming new la-
bels
1: while not converge do
2: Start iterations t:= 1,2,. . . do
3: Step 1 - Training model: find λ∗ and p(w)
4: for n = 1, 2, . . . ,N,
5: maxλ
∑
n∈{1,...,N}
(
λn + log(1 − λn/c)
)
−
6: 12
(∑
n∈{1,...,N} λn pn(yn)xn,Tn
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
)T
7:
(∑
n∈{1,...,N} λn pn(yn)xn,Tn
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
)
8: s.t. λ ≥ 0
9: p(w) = 1Zw(λ) p0(w) exp
(∑
n∈{1,...,N} λn pn(yn)wT xn,Tn+
10:
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnwT zn,t
)
11: Step 2 - Prediction: predict the label of a new exam-
ple (xnew)
12: yˆ = sign
(( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn +
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
)T
xnew
)
13: end for
3.3. UQ-CHI with rejection option
Typically the performance of a prediction model is evaluated
based on its accuracy, on a scheme of classifying all samples,
regardless of the degree of confidence associated with the clas-
sification of the samples. However, accuracy is not the only
measurement that can be used to judge the model’s perfor-
mance. In many healthcare application, it is safer to make pre-
dictions when the confidence assigned to the classification is
relatively high, rather than classify all samples even if confi-
dence is low. In this case, a sample can be rejected if it doesn’t
fit into any of the classes. In pattern recognition, this problem
is typically solved by estimating the class conditional probabil-
ities and rejecting the samples that have the lowest class pos-
terior probabilities, that are the most unreliable samples. As
UQ-CHI enables uncertainty quantification, here, we create a
rejection option in prediction to show the utility of uncertainty
quantification in practice. The basic idea of rejection option is
that the prediction model rejects to generate a prediction if the
uncertainty is higher than a given threshold. In other words,
a sample that is most likely to be misclassified is rejected as
described below:
max p(w|xi) < T i = 1, . . . ,N (19)
Here, T is the rejection rate. The samples xi are rejected for
which the maximum posterior probability p(w|xi) is below a
threshold. And a sample is accepted when:
max p(w|xi) ≥ T i = 1, . . . ,N (20)
Thus, we define a classification with rejection as yˆre jection,
where, if a sample is rejected yˆre jectioni = 0, denotes rejection,
else, yˆre jectioni = yˆi, where, yˆi corresponds to the classification of
the ith sample defined in Eq. (18).
3.4. Tractability of UQ-CHI related to design of prior distribu-
tion
Recall that by applying the MED to our optimization problem
we no longer learn the model parameter, and instead, we spec-
ify the probability distributions. These distributions give rise
to penalty functions for the model and the margins via KL-
divergence. In detail, the model distribution will give rise to
a divergence term KL(p(w)||p0(w)), and the margin distribu-
tion will give rise to the divergence term KL(p(γ)||p0(γ)) which
corresponds to the regularization penalty and the loss function
respectively. The trade-off between classification loss and reg-
ularization now are on a common probabilistic scale, since both
terms are based on probability distributions and KL-divergence.
Hence, there is a relationship between defining a prior distri-
bution over margins and parameters and defining the objective
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Algorithm name UQ-CHI
CHILabel ratio Training ratio Rejection rateLow = 20 Medium = 40 High = 60
Low = 10
30 0.69 0.74 0.81 0.61
50 0.73 0.76 0.83 0.62
70 0.75 0.77 0.85 0.65
Medium = 20
30 0.66 0.72 0.73 0.55
50 0.69 0.73 0.74 0.60
70 0.71 0.75 0.78 0.64
High = 50
30 0.64 0.69 0.72 0.53
50 0.67 0.71 0.73 0.56
70 0.70 0.73 0.75 0.60
Table 1: Corresponding testing accuracies for different rejection options for the simulated dataset
function and the penalty term in the original function. Re-
call that, γn are the classification margins as slack variables
in the optimization which represent the minimum margin that
ynD(Xn; w) must satisfy. Hence, the choice of the margin dis-
tribution corresponds to the use of the slack variables in the
formulation of the UQ-CHI. For example, in our case we set
p0(γn) = ce−c(1−γn) and γn ≤ 1. If we mathematically expand
the normalization function in (10), we get the two terms Zw(λ)
and Zγ(λ) as shown in (14), and given the choice of margin pri-
ors in Section 3.1 we get:
logZγn (λn) = log
∫ 1
γn=−∞
c exp
(
−c(1 − γn)) exp ( − λnγn)dγn.
(21)
From (21) we can see that a penalty occurs when the margins
are smaller than E[γn] = 1 − 1c , and any margins larger than
this would not be penalized. The margin distribution becomes
peaked when γn = 1 that is when c→ ∞, and this is equivalent
to having fixed margins. If the margin values are held fixed the
discriminant function might not be able to separate the training
examples with such pre-specified margin values. Because of
non-separable datasets this will generate an empty convex hull
for the solution space. Thus, we need to revisit the setting of
the margin values, and the loss function upon them. The pa-
rameter c will play an almost identical role as the regularization
parameter which upper bounds the Lagrange multipliers. Note,
if the objective function J() grow without a bound, it may gen-
erate a search space for parameters that are no longer a convex
hull. This compromises the uniqueness and solvability of the
problem. Therefore, the selection of a prior forms a concave
function J() for a unique optimum in the Lagrange multiplier
space.
4. Numerical studies
In this section, we design our simulation studies to evaluate
the efficacy of UQ-CHI in terms of prediction and uncertainty
quantification, in comparison with the CHI model under a vari-
ety of practical scenarios.
4.1. Simulated dataset
We simulate data following the procedure described as follows.
The synthetic dataset is generated with two classes with partial
labels. We conduct several experiments with the simulated data
to investigate the performance of our method across different
settings. Without loss of generality, we assume that there are
two groups, normal vs. diseased with a proportion of 60% of
class normal and 20% of complete labels. For all the experi-
ments, we set the number of features d = 90, For each class, we
simulate 50 subjects, where we assumed that xkn,t ∼ N
(
u, σ2k
)
for
k ∈ {1, . . . , d}.
4.2. Incomplete labels and length of longitudinal data
UQ-CHI can handle partial labels well, i.e., by assigning a
prior distribution of the labels and obtaining posterior distri-
butions after model training, in our experiment, we consider
a low, medium and high level of label availability, i.e., 10%,
20% and 50% of unlabeled examples. Also, we evaluate our
methodology’s robustness in the presence of down-sampling of
the training data, i.e., only using a percentage of the data (for
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example, ranging from 30%, 50% and 70%), to train both UQ-
CHI and CHI models. A model that can predict well with less
longitudinal data holds great value in clinical applications.
4.3. Uncertainty quantification with rejection option
As mentioned in 3.3, UQ-CHI has a unique capacity of rejec-
tion option. The algorithm rejects to predict on a sample if it
cannot be predicted reliably. The key parameter is the threshold
that will be used in the rejection option. In our experiments, we
use several levels of the threshold to create a range of rejection
options from loose to strict, and further calculate the resulting
accuracies on the predictions on the accepted samples. Specif-
ically, we vary the size of the rejection region from 20%, 40%,
to 60%.
4.4. Parameter tuning and validation
In our experiments, we randomly split the data into two parts,
one for training and one for testing. For the training dataset, we
use 10-fold cross-validation to tune the parameters. The aver-
age accuracies from the split of the testing dataset are reported
in the result section. In Section 3.4 we specify under what
condition the computation would remain tractable. It has been
pointed out that, based on the choice of the margin distribution
described in 3.4, γn is bounded by the parameter c. Recall that
c is a parameter in the prior for the margins. Therefore, the pa-
rameter c will play an important role. Hence, we conduct exper-
iments with the parameter c chosen from (1.5, 3, 5, 10, 20, 100)
to see the impact of various choices of c on the testing accuracy.
4.5. Discussion
In the following, we discuss the tractability of the model given
the simulated data for various choices of the parameter c in Ta-
ble 2. We simulated different selection of the parameter c to
check its impact on the testing accuracy. If we observe that in-
creasing this parameter imposes no effect on the performance,
we would then ignore the higher values for reasons discussed
in Section 3.4. The results show that for a more significant
quantity of parameter c the accuracy decreases. As shown in
Table 2, additional potential terms of the parameter c would not
carry huge effects as the margin distribution may have become
at its peak (γn) which is equivalent to have fixed margins. Note
that to test the impact of the parameter c we simulated the data
with a proportion of 60% of class normal and 20% complete
labels. Here we can observe that after increasing the values for
the parameter c beyond 5, the performance of the model doesn’t
change significantly, which indicates that the margin distribu-
tion may have become at its peak, and hence it is equal to a
fixed value. Higher values of this parameter generate relatively
similar performance. Consequently, lower values of c preserve
flexibility to estimate a distribution over parameters instead of
using fixed margins.
Next, we examine how the incomplete label information would
affect the performance of UQ-CHI with regards to the testing
accuracy given different sampling ratios in Table 3. A model
which can be trained with less training data is more promising
in healthcare applications where the data collection is relatively
costlier than other real-world applications. The results in Ta-
ble 3 show that with even a ratio of 50% of incomplete label
information the UQ-CHI can perform with a testing accuracy
of 74%. This confirms that the model is capable of performing
well in the face of lack of label information.
Incorporating a rejection option into the model improves the
prediction accuracy of classifiers. There is a general relation-
ship between the testing accuracy and rejection rate: the test-
ing accuracy increases monotonically with increasing rejection
rate. The testing accuracies for different rejection options are
reported in Table 1. Comparisons of varying rejection rates
for the UQ-CHI confirms that for a high rejection rate of 60%,
the testing accuracy could go up to 81% for a given label ra-
tio of 10%, which in comparison with a lower rejection rate,
this can be a promising result. In Table 1, we also compared
our methodology with CHI framework. Recall that CHI is not
strictly a supervised learning problem. In [28], both simulation
studies and real-world applications demonstrated that without
label information, CHI method could still be trained and used
to predict. However, we show that the UQ-CHI can generate
relativity a better performance than CHI by incorporating the
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rejection option. UQ-CHI can obtain a testing accuracy in a
range of 75% to 81% for a given rejection rate of 60% and a
labeling ratio of 10% − 50%.
Parameter c Testing accuracy
1.5 81.2
3 80.2
5 79.8
10 77.2
20 77.3
100 76.1
Table 2: Model average testing accuracy (%) for simulated dataset
5. Real-world application on Alzheimer’s disease
We further test UQ-CHI on an Alzheimer’s disease data which
exhibited monotonic disease progression. We use the FDG-PET
images of 162 patients (Alzheimer’s Disease: 74, Normal ag-
ing: 88) downloaded from the ADNI (www.loni.usc.edu/
ADNI). The data is sampled at irregular time points where each
patient has at least three time points and at most seven-time
points. The data is preprocessed, and the Automated Anatom-
ical Labeling (AAL) is used to segment each image into 116
anatomical volumes of interest (AVOIs). For this study, 90
AVOIs that are in the cerebral cortex are selected (each AVOI
becomes a variable here). According to the mechanism of FDG-
PET, the measurement data of each region are the local average
FDG binding counts, which represents the degree of glucose
metabolism. The glucose metabolism declines as the function
of aging, and the progression of many neurodegenerative dis-
eases such as AD further accelerates this declination. Thus,
ADNI dataset facilitates a perfect application example to test
the proposed method. While the ADNI dataset consists of fully
labeled examples, we exploit the dataset settings to create a va-
riety of uncertainties to the label information.
The results for tuning the parameter c for the ADNI dataset is
reported in Table 4. The results show that for a more signif-
icant quantity of parameter c the accuracy decreases. Table 5
shows the performance of the UQ-CHI across different uncer-
tainty levels as well as different sampling ratios. The proposed
method shows an excellent capability to quantify the uncertain-
Sample ratio Label ratioLow = 10% Medium = 20% High = 50%
30 0.85 ± 0.033 0.80 ± 0.032 0.74 ± 0.033
50 0.86 ± 0.060 0.83 ± 0.053 0.76 ± 0.027
70 0.88 ± 0.074 0.85 ± 0.041 0.78 ± 0.037
Table 3: The average classification accuracies and standard deviations (%) for
the simulated dataset
Parameter c Testing accuracy
1.5 78.8
3 77.9
5 77.3
10 75.3
20 72
100 68.9
Table 4: Model average testing accuracy (%) for ADNI dataset
ties for the real-world dataset. As shown in Table 5, The UQ-
CHI is even capable of dealing with a data that has 50% of
incomplete labels with an accuracy in the range of 70% − 77%
for the ADNI dataset.
On the other hand, we show that by only using a small propor-
tion of the training samples as low as 30% of the data, we still
can maintain reasonable performance in a range of 70%− 82%,
which indicates that UQ-CHI can be trained with less training
data. The rejection options against the testing accuracy as well
as these values against the training ratios are shown in Tables
6. Incorporating a rejection option into the model improves
the prediction accuracy of classifiers. Comparisons of different
rejection rates for the UQ-CHI confirms that for a high rejec-
tion rate of 60%, the testing accuracy could go up to 80% or
higher, which compared with a lower rejection rate, this can be
a promising result.
6. Conclusion
In this paper, we develop the UQ-CHI method to enable un-
certainty quantification for continuous patient monitoring. This
Sample ratio Label ratioLow = 10% Medium = 20% High = 50%
30 0.82 ± 0.022 0.79 ± 0.052 0.70 ± 0.032
50 0.84 ± 0.014 0.82 ± 0.005 0.74 ± 0.049
70 0.87 ± 0.040 0.83 ± 0.032 0.76 ± 0.043
Table 5: The average classification accuracies and standard deviations (%) for
ADNI dataset
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Algorithm name UQ-CHI
CHILabel ratio Training ratio Rejection rateLow = 20 Medium = 40 High = 60
Low = 10
30 0.71 0.76 0.83 0.64
50 0.75 0.78 0.84 0.66
70 0.77 0.79 0.87 0.70
Medium = 20
30 0.67 0.71 0.72 0.58
50 0.70 0.72 0.75 0.62
70 0.71 0.75 0.76 0.63
High = 50
30 0.66 0.70 0.71 0.55
50 0.69 0.71 0.73 0.58
70 0.71 0.72 0.74 0.62
Table 6: Corresponding testing accuracies for different rejection options for the ADNI dataset
probabilistic generalization will facilitate a few extensions to
the basic CHI model for decision-making purposes. For exam-
ple, in many degenerative disease conditions such as AD, it is
essential to triage patients to determine the priority of resource
allocations and patient care. Therefore, the UQ-CHI framework
would equip us with an optimal decision considering imperfect
and continuous delivery of knowledge. In the future, we would
like to extend this method to other diseases that may show dif-
ferent degradation characteristics in the context of degenerative
diseases. Another extension of this methodology is to apply on
a non-linear index and further explore the feasibility of varying
discriminant functions.
Appendix A. Proof to Lemma 3.1
Proof. By adding a set of dual variables, one for each con-
straint, the Lagrangian of the optimization problem in (3) can
be written as:
L(p(w, λ)) = KL(p(w)||p0(w)) −∑
n
λn
(
ynEp(w)[D(Xn|w)] − 1),
(A.1)
In order to find the solution to Eq. (3), and given the definition
of the KL-divergence in (5) we require,
∂L
∂p(w)
= log p(w) − log p0(w) −
∑
n
λnynD(Xn|w) = 0,
(A.2)
The solution to the MED optimization problem has the follow-
ing general form:
p(w∗) =
1
Z(λ)
p0(w) exp
(∑
n
λnynD(Xn|w)
)
. (A.3)
Here, Z(λ) is the normalization constant defined in (10), then
the general exponential form of the solution becomes:
g(λ) = L(p(w∗), λ)
=
∫
1
Z(λ)
p0(w) exp
(∑
n
λnynD(Xn|w)
)
(∑
n
λnynD(Xn|w) − log p0(w) − log(Z)
)
dw−
∑
n
λn
(
yn
∫
1
Z(λ)
p0(w) exp
(∑
n
λnynD(Xn|w)
)
D(Xn|w)dw − 1
)
=
∑
n
λn − log Z(λ).
(A.4)
Hence, the dual of the MED problem can be shown in (9).
Appendix B. Proof to Lemma 3.3
Proof. Let Z(λ) be the normalization constant defined in Eq.
(10), given the constraints in (8) the normalization constant can
be reformulated as follows:
Z(λ) =
∫
p0(w, γ) (B.1a)
exp
( ∑
n∈{1,...,N}
λn[p(yn)D(xn,Tn | w) − γn]+ (B.1b)
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λn
[M(zn,t |w) − γn])dwdγ, (B.1c)
=
∫
P0(w) exp
( ∑
n∈{1,...,N}
λn pn(yn)wT xn,Tn+ (B.1d)
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnwT zn,t
)
(B.1e)
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P0(γ) exp
(
−
∑
n∈{1,...,N}
λnγn
)
dwdγ, (B.1f)
Given the priors in (7), each term in Eq. (B.1) can be reformu-
lated as follows: For the term in (B.1d) and (B.1e) we have the
followings:
Zw(λ) =
∫
P0(w) exp
( ∑
n∈{1,...,N}
λn pn(yn)wT xn,Tn+
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnwT zn,t
)
dw
=
∫ ∞
−∞
1√
2pi
exp
(
− 1
2
wT w
)
exp
( ∑
n∈{1,...,N}
λn pn(yn)wT xn,Tn+
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnwT zn,t
)
dw
=
∫ ∞
−∞
1√
2pi
exp
(
− 1
2
(
wT w − 2wT ( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn+
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
)))
dw
= exp
(
1
2
( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn +
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
)T
( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn +
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
))
∫ ∞
−∞
exp
(
− 1
2
(
w − ( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn+
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
))T
(
w − ( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn +
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
)))
= exp
(
1
2
( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn +
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
)T
( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn +
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
))
,
(B.2)
And for the last term (B.1f) we have the following:
Zγ(λ) = P0(γ) exp
(− ∑
n∈{1,...,N}
λnγn
)
dγ
=
n∏
1
∫
P0(γn) exp
(−λnγn)dγn
=
∫ 1
−∞
c exp
( − c + cγn) exp ( − λnγn)dγn
=
c
c − λn exp
( − λn)
=
1
1 − λt/c exp
( − λn),
(B.3)
Substituting the results from Eq. (B.2) and (B.3) in (B.1), re-
sults in Eq. (14).
Appendix C. Proof to Lemma 3.5
Proof. Given the marginal distribution p(w) in (17) and
the convex combination of discriminant functions defined as∫
p(w)D(x|w)dw we have the following:∫
p(w)D(x|w)dw =
∫
p(w)(wT xnew)dw
=
1
Zw(λ)
wT xnew p0(w)
exp
( ∑
n∈{1,...,N}
λn pn(yn)wT xn,Tn+
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnwT zn,t
)
dw,
(C.1)
Where, given the prior distributions, (C.1) can be written as:
=
∫ ∞
−∞
wT xnew
Zw(λ)
√
2pi
exp
(
− 1
2
wT w + wT
( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn+
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
))
dw
=
∫ ∞
−∞
wT xnew√
2pi
exp
( −1
2
(
w − ( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn+
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
))T (
w − ( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn+
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
)))
dw
=
( ∑
n∈{1,...,N}
λn pn(yn)xn,Tn +
∑
n∈{1,...,N}
t∈{1,...,Tn−1}
λnzn,t
)T
xnew.
(C.2)
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